tiprankstipranks
NAVCO Pharmaceuticals Inc (TSE:NAV)
TSXV:NAV
Canadian Market

NAVCO Pharmaceuticals Inc (NAV) Financial Statements

1 Followers

NAVCO Pharmaceuticals Inc Financial Overview

NAVCO Pharmaceuticals Inc's market cap is currently ―. The company's EPS TTM is C$-0.458; its P/E ratio is -0.09; NAVCO Pharmaceuticals Inc is scheduled to report earnings on May 28, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -270.15K-C$ -3.34MC$ 8.30KC$ -5.86K
EBITDAC$ -259.19K-C$ -3.31MC$ 8.30KC$ -5.86K
Net Income Common StockholdersC$ -271.95K-C$ -3.34MC$ 8.30KC$ -5.86K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 79.60KC$ 234.67KC$ 1.44MC$ 0.00C$ 104.00
Total AssetsC$ 606.85KC$ 931.84KC$ 2.61MC$ 94.75KC$ 93.50K
Total DebtC$ 108.26KC$ 112.64KC$ 231.33KC$ 155.00C$ 0.00
Net DebtC$ 28.66KC$ -122.03KC$ -1.21MC$ 155.00C$ -104.00
Total LiabilitiesC$ 791.39KC$ 844.38KC$ 1.37MC$ 90.87KC$ 97.93K
Stockholders EquityC$ -184.50KC$ 87.45KC$ 1.24MC$ 3.87KC$ -4.43K
Cash Flow-
Free Cash Flow--C$ -1.30M-C$ -21.44K
Operating Cash Flow--C$ -1.30M-C$ -21.44K
Investing Cash Flow-----
Financing Cash Flow--C$ 2.02M--
Currency in CAD

NAVCO Pharmaceuticals Inc Earnings and Revenue History

NAVCO Pharmaceuticals Inc Debt to Assets

NAVCO Pharmaceuticals Inc Cash Flow

NAVCO Pharmaceuticals Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis